Vaccines and Related Biological Products Advisory Committee
November 3, 2000 Meeting
Date and Time
The meeting will be held on November 3, 2000 from 8:00 am until 5:30 pm.
Location
Holiday Inn, Versailles Ballrooms I and II, 8120 Wisconsin Avenue, Bethesda, MD., 301-652-2000
Contact Person
Nancy T. Cherry or Denise H. Royster, 301-827-0314, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 12391. Please call the Information Line for up-to-date information on this meeting.
Agenda (Updated)
On November 3, 2000 at 8:30 am EST the meeting will be called to order by the presiding chairperson. Beginning at 8:40 am there will be an update on Transmissible Spongiform Encephalopathies issues. At approximately 9:10 am, and for the remainder of the day, the topic of discussion will be the CPDT Vaccine Absorbed from Aventis Pasteur Limited of Canada. Open public hearings will be announced at 1:50 pm and 3:20 pm. The meeting will adjourn at approximately 5:30 pm EST.
Oral Presentations
Between approximately 1:50 pm and 2:20 pm; and 3:20 pm and 3:50 pm oral presentations from the public will be scheduled. Those desiring to make formal oral presentations should notify the contact person before October 26, 2000.
Closed Committee Deliberations
From 8:00 am until 8:20 am the meeting will be closed to permit discussion and review of trade secret and/or confidential information (5 U.S.C. 552b(c)(4)).
|
